|
1
|
Parisi R, Symmons DP, Griffiths CE and
Ashcroft DM: Identification and Management of Psoriasis and
Associated ComorbidiTy (IMPACT) project team. Global epidemiology
of psoriasis: A systematic review of incidence and prevalence. J
Invest Dermatol. 133:377–385. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Henes JC, Ziupa E, Eisfelder M, Adamczyk
A, Knaudt B, Jacobs F, Lux J, Schanz S, Fierlbeck G, Spira D, et
al: High prevalence of psoriatic arthritis in dermatological
patients with psoriasis: A cross-sectional study. Rheumatol Int.
34:227–234. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tey HL, Ee HL, Tan AS, Theng TS, Wong SN
and Khoo SW: Risk factors associated with having psoriatic
arthritis in patients with cutaneous psoriasis. J Dermatol.
37:426–430. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Raposo I and Torres T: Nail psoriasis as a
predictor of the development of psoriatic arthritis. Actas
Dermosifiliogr. 106:452–457. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rouzaud M, Sevrain M, Villani AP,
Barnetche T, Paul C, Richard MA, Jullien D, Misery L, Le Maître M,
Aractingi S, et al: Is there a psoriasis skin phenotype associated
with psoriatic arthritis? Systematic literature review. J Eur Acad
Dermatol Venereol. 28 (Suppl 5):S17–S26. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Taylor W, Gladman D, Helliwell P,
Marchesoni A, Mease P and Mielants H: CASPAR Study Group:
Classification criteria for psoriatic arthritis: Development of new
criteria from a large international study. Arthritis Rheum.
54:2665–2673. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Khondker L and Khan SI: Association of
rheumatoid factor and uric acid with psoriatic arthritis: A review.
Mymensingh Med J. 23:609–613. 2014.PubMed/NCBI
|
|
8
|
Kurowska W, Kuca-Warnawin EH, Radzikowska
A and Maśliński W: The role of anti-citrullinated protein
antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent
Eur J Immunol. 42:390–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Perez-Alamino R, Garcia-Valladares I,
Cuchacovich R, Iglesias-Gamarra A and Espinoza LR: Are anti-CCP
antibodies in psoriatic arthritis patients a biomarker of erosive
disease? Rheumatol Int. 34:1211–1216. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
WMA declaration of Helsinki-ethical
principles for medical research involving human subjects.
https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/.
Accessed July 17, 2020.
|
|
11
|
Zlatkovic-Svenda M, Kerimovic-Morina D and
Stojanovic RM: Psoriatic arthritis classification criteria: Moll
and wright, ESSG and CASPAR-a comparative study. Acta Reumatol
Port. 38:172–178. 2013.PubMed/NCBI
|
|
12
|
Finlay AY: Current severe psoriasis and
the rule of tens. Br J Dermatol. 152:861–867. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Andrade TL, Camelier AA, Rosa FW, Santos
MP, Jezler S and Pereira e Silva JL: Applicability of the 12-item
short-form health survey in patients with progressive systemic
sclerosis. J Bras Pneumol. 33:414–422. 2007.(In English,
Portuguese). PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lukas C, Landewé R, Sieper J, Dougados M,
Davis J, Braun J, van der Linden S and van der Heijde D: Assessment
of SpondyloArthritis international Society. Development of an
ASAS-endorsed disease activity score (ASDAS) in patients with
ankylosing spondylitis. Ann Rheum Dis. 68:18–24. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Assesment of Spondyloarthritis
International Society: ASDAS calculator. https://www.asas-group.org/clinical-instruments/asdas-calculator/.
Accessed November 10, 2018.
|
|
16
|
Eker YÖ, Pamuk ÖN, Pamuk GE, Dönmez S and
Çakır N: The frequency of anti-CCP antibodies in patients with
rheumatoid arthritis and psoriatic arthritis and their relationship
with clinical features and parameters of angiogenesis: A
comparative study. Eur J Rheumatol. 1:67–71. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Inanc N, Dalkilic E, Kamali S,
Kasapoglu-Günal E, Elbir Y, Direskeneli H and Inanc M: Anti-CCP
antibodies in rheumatoid arthritis and psoriatic arthritis. Clin
Rheumatol. 26:17–23. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Korendowych E, Owen P, Ravindran J,
Carmichael C and McHugh N: The clinical and genetic associations of
anti-cyclic citrullinated peptide antibodies in psoriatic
arthritis. Rheumatology (Oxford). 44:1056–1060. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Alenius GM, Berglin E and Rantapää
Dahlqvist S: Antibodies against cyclic citrullinated peptide (CCP)
in psoriatic patients with or without joint inflammation. Ann Rheum
Dis. 65:398–400. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Candia L, Marquez J, Gonzalez C, Santos
AM, Londoño J, Valle R, Zabaleta J, Yaqub Z and Espinoza LR: Low
frequency of anticyclic citrullinated peptide antibodies in
psoriatic arthritis but not in cutaneous psoriasis. J Clin
Rheumatol. 12:226–229. 2006.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee AN, Beck CE and Hall M: Rheumatoid
factor and anti-CCP antibodies in rheumatoid arthritis: A review.
Clin Lab Sci. 21:15–18. 2008.PubMed/NCBI
|
|
22
|
Popescu C, Zofotă S, Bojincă V and Ionescu
R: Anti-cyclic citrullinated peptide antibodies in psoriatic
arthritis-cross-sectional study and literature review. J Med Life.
6:376–382. 2013.PubMed/NCBI
|
|
23
|
Maejima H, Aki R, Watarai A, Shirai K,
Hamada Y and Katsuoka K: Antibodies against cyclic citrullinated
peptide in Japanese psoriatic arthritis patients. J Dermatol.
37:339–345. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Behrens F, Koehm M, Thaçi D, Gnann H,
Greger G, Maria Wittig B and Burkhardt H: Anti-citrullinated
protein antibodies are linked to erosive disease in an
observational study of patients with psoriatic arthritis.
Rheumatology (Oxford). 55:1791–1795. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Grover C, Kashyap B, Daulatabad D, Dhawan
A and Kaur IR: Significance of anti-cyclic citrullinated peptide
autoantibodies in immune-mediated inflammatory skin disorders with
and without arthritis. Indian J Dermatol. 61:510–514.
2016.PubMed/NCBI View Article : Google Scholar
|
